Mackenzie Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40,288
| Closed | -$977K | – | 1716 |
|
|
2025
Q1 | $977K | Buy |
40,288
+5,757
| +17% | +$140K | ﹤0.01% | 990 |
|
|
2024
Q4 | $721K | Buy |
34,531
+19,705
| +133% | +$411K | ﹤0.01% | 1029 |
|
|
2024
Q3 | $295K | Buy |
14,826
+810
| +6% | +$16.1K | ﹤0.01% | 1197 |
|
|
2024
Q2 | $217K | Buy |
+14,016
| New | +$217K | ﹤0.01% | 1313 |
|
|
2022
Q4 | – | Sell |
-55,512
| Closed | -$712K | – | 1465 |
|
|
2022
Q3 | $712K | Sell |
55,512
-476
| -0.9% | -$6.11K | ﹤0.01% | 867 |
|
|
2022
Q2 | $392K | Buy |
55,988
+1,292
| +2% | +$9.05K | ﹤0.01% | 995 |
|
|
2022
Q1 | $453K | Sell |
54,696
-23,922
| -30% | -$198K | ﹤0.01% | 1005 |
|
|
2021
Q4 | $532K | Buy |
+78,618
| New | +$532K | ﹤0.01% | 991 |
|
|
2020
Q4 | – | Sell |
-10,900
| Closed | -$32K | – | 1050 |
|
|
2020
Q3 | $32K | Buy |
+10,900
| New | +$32K | ﹤0.01% | 970 |
|